SCHEMBL19987353

SCHEMBL19987353

CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)C(F)(F)C1(C)C)Oc1ccccc1

nearest known ligand 0.78

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.78
CYP2C9 P11712 2/20 0.78
BTN3A1 O00481 5/20 0.41
P2RY2 P41231 3/20 0.39
P2RY6 Q15077 2/20 0.39
P2RY14 Q15391 2/20 0.39
P2RY4 P51582 1/20 0.37
POLA1 P09884 1/20 0.36
P2RY12 Q9H244 2/20 0.34
ENTPD2 Q9Y5L3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19987219 0.93 CYP3A4 (0.74) CYP3A4CYP2C9BTN3A1P2RY2P2RY6
SCHEMBL21511241 0.93 CYP3A4 (0.74) CYP3A4CYP2C9BTN3A1P2RY2P2RY6
SCHEMBL21511240 0.93 CYP3A4 (0.74) CYP3A4CYP2C9BTN3A1P2RY2P2RY6
SCHEMBL19987182 0.93 CYP3A4 (0.74) CYP3A4CYP2C9BTN3A1P2RY2P2RY6
Sofosbuvir SCHEMBL24134038 0.87 CYP3A4 (1.00) CYP3A4CYP2C9BTN3A1P2RY2P2RY6
Sofosbuvir SCHEMBL20705434 0.87 CYP3A4 (1.00) CYP3A4CYP2C9BTN3A1P2RY2P2RY6
Sofosbuvir SCHEMBL20733226 0.87 CYP3A4 (1.00) CYP3A4CYP2C9BTN3A1P2RY2P2RY6
Sofosbuvir SCHEMBL22236662 0.87 CYP3A4 (1.00) CYP3A4CYP2C9BTN3A1P2RY2P2RY6
Sofosbuvir SCHEMBL20869402 0.87 CYP3A4 (1.00) CYP3A4CYP2C9BTN3A1P2RY2P2RY6
Sofosbuvir SCHEMBL23348827 0.87 CYP3A4 (1.00) CYP3A4CYP2C9BTN3A1P2RY2P2RY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018049535-A1 NUCLEOSIDE ANALOGUES AND METHODS OF USE THEREOF LCB PHARMA INC. (CA) 2018-03-22 WO disclosed